I don’t agree this is shell value. Look at VTI it’s making $14m AUD a year against $7m market cap and in the eye / healthcare space woth unique myopia lense tech. Far closer to break even than EYE also
we all like upside comparisons where we will fork $300m market cap but investors should be aware based on them as a comparison if EYE didn’t make the most of the opportunity and revenue stayed flat with continued losses could fall to 4c.
hust saying this is the murky end of the sharemarket pond and there is no guaranteed valuation floor until a share is CF+ based on NPAT multiples
Nova Eye Medical (EYE) Discussion, page-1094
-
- There are more pages in this discussion • 2,094 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.23M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.0¢ | $24.11K | 132.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 137086 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 30000 | 1 |
View Market Depth
| Last trade - 14.41pm 04/10/2024 (20 minute delay) ? |
| EYE (ASX) Chart |